Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Residual melanoma after an excisional biopsy is an independent prognostic factor for local recurrence and overall survival.

Hocevar M, Dragonja Z, Pilko G, Gazic B, Zgajnar J.

Eur J Surg Oncol. 2014 Oct;40(10):1271-5. doi: 10.1016/j.ejso.2014.03.002.

PMID:
24656456
2.

Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA.

Ann Surg. 2012 Jan;255(1):128-33. doi: 10.1097/SLA.0b013e3182306c72.

PMID:
21975320
3.

Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.

Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E.

Br J Cancer. 2005 Feb 28;92(4):662-7.

4.

Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy.

Bolshinsky V, Lin MJ, Serpell J, Leung M, Wolfe R, McLean C, Kelly JW.

J Am Acad Dermatol. 2016 Jan;74(1):102-7. doi: 10.1016/j.jaad.2015.08.065.

PMID:
26601566
5.

Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma.

Mills JK, White I, Diggs B, Fortino J, Vetto JT.

Am J Surg. 2013 May;205(5):585-90; discussion 590. doi: 10.1016/j.amjsurg.2013.01.023.

PMID:
23592167
6.

[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].

de Vries M, Jager PL, Suurmeijer AJ, Plukker JT, van Ginkel RJ, Hoekstra HJ.

Ned Tijdschr Geneeskd. 2005 Aug 13;149(33):1845-51. Dutch.

PMID:
16128183
7.

Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.

Egger ME, Bhutiani N, Farmer RW, Stromberg AJ, Martin RC 2nd, Quillo AR, McMasters KM, Scoggins CR.

Surgery. 2016 May;159(5):1412-21. doi: 10.1016/j.surg.2015.12.002.

PMID:
26775577
8.

Sentinel-node biopsy or nodal observation in melanoma.

Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ; MSLT Group..

N Engl J Med. 2006 Sep 28;355(13):1307-17. Erratum in: N Engl J Med. 2006 Nov 2;355(18):1944.

9.

Is sentinel lymph node biopsy of therapeutic relevance for melanoma?

Möhrle M, Schippert W, Rassner G, Garbe C, Breuninger H.

Dermatology. 2004;209(1):5-13. Erratum in: Dermatology. 2005;210(1):84.

PMID:
15237261
10.

Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.

Gannon CJ, Rousseau DL Jr, Ross MI, Johnson MM, Lee JE, Mansfield PF, Cormier JN, Prieto VG, Gershenwald JE.

Cancer. 2006 Dec 1;107(11):2647-52.

11.

Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.

Lee NC, Spillane AJ, Pang TC, Haydu LE, Uren RF.

Ann Surg Oncol. 2012 Jan;19(1):280-6. doi: 10.1245/s10434-011-1872-3. Erratum in: Ann Surg Oncol. 2011 Dec;18 Suppl 3:S319-20.

PMID:
21833669
12.

Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.

Wagner JD, Gordon MS, Chuang TY, Coleman JJ 3rd, Hayes JT, Jung SH, Love C.

Cancer. 2000 Jul 15;89(2):453-62.

PMID:
10918179
13.

Pigmentation in the sentinel node correlates with increased sentinel node tumor burden in melanoma patients.

van Lanschot CG, Koljenović S, Grunhagen DJ, Verhoef C, van Akkooi AC.

Melanoma Res. 2014 Jun;24(3):261-6. doi: 10.1097/CMR.0000000000000061.

PMID:
24608184
14.

Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.

Sartore L, Papanikolaou GE, Biancari F, Mazzoleni F.

Int J Surg. 2008 Jun;6(3):205-9. doi: 10.1016/j.ijsu.2008.03.003.

15.

Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.

Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, Hagendoorn L, Martin RC 2nd, McMasters KM.

Am J Surg. 2011 Dec;202(6):659-64; discussion 664-5. doi: 10.1016/j.amjsurg.2011.06.048.

PMID:
22137134
16.

Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas.

White I, Fortino J, Curti B, Vetto J.

Am J Surg. 2014 May;207(5):702-7; discussion 707. doi: 10.1016/j.amjsurg.2013.12.022.

PMID:
24791630
17.

The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma.

Mohebati A, Ganly I, Busam KJ, Coit D, Kraus DH, Shah JP, Patel SG.

Ann Surg Oncol. 2012 Dec;19(13):4307-13. doi: 10.1245/s10434-012-2468-2.

PMID:
22766985
18.

Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.

Statius Muller MG, van Leeuwen PA, van Diest PJ, Pijpers R, Nijveldt RJ, Vuylsteke RJ, Meijer S.

World J Surg. 2002 Dec;26(12):1405-11.

PMID:
12297910
19.

Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?

Shen P, Guenther JM, Wanek LA, Morton DL.

Ann Surg Oncol. 2000 Mar;7(2):114-9.

PMID:
10761789
20.

The effect of delay time between primary melanoma biopsy and sentinel lymph node dissection on sentinel node status, recurrence, and survival.

Parrett BM, Accortt NA, Li R, Dosanjh AS, Thummala S, Kullar R, Cleaver JE, Kashani-Sabet M, Leong SP.

Melanoma Res. 2012 Oct;22(5):386-91. doi: 10.1097/CMR.0b013e32835861f6.

PMID:
22955010
Items per page

Supplemental Content

Support Center